VIVUS has cut the retail cash price of Qsymia, its phentermine/topiramate extended‑release capsule for chronic weight management, to under...

Journey Medical will meet investors at two New York conferences in October: the 4th Annual ROTH Healthcare Opportunities Conference...

Nurexone Biologic reported new preclinical data for ExoPTEN, an exosome-delivered siRNA therapy targeting PTEN, showing a reproducible, dose-dependent restoration...

Medical Affairs has never carried more strategic weight—or faced greater pressure to prove its value. Across Europe, leaders are...

Nasus Pharma has signed comprehensive agreements with Aptar to support clinical development and planned commercialization of NS002, an intranasal...

Catalyst Pharmaceuticals will present a cluster of real-world evidence analyses across the October congresses, spanning the Child Neurology Society,...

60 Degrees Pharmaceuticals is launching B-FREE, a Phase 2 open-label trial evaluating the ARAKODA (tafenoquine) regimen as a potential...

Novo Nordisk has agreed to acquire Akero Therapeutics for up to $5.2 billion in cash, adding the FGF21 analogue...

Digital Utilities Ventures, operating as Easy Environmental Solutions, has completed FINRA’s corporate action process, finalizing its acquisition of Lifestyle...

Catalyst Pharmaceuticals will present new real-world evidence across Duchenne muscular dystrophy and Lambert-Eaton myasthenic syndrome at major neuromuscular meetings...